In silico molecular docking analysis of the human Argonaute 2 PAZ domain reveals insights into RNA interference

Journal of Computer-Aided Molecular Design

Volumn 27, Issue 7, 2013, Pages 605-614

  Kandeel, Mahmoud ^a,b   Kitade, Yukio ^b  

^a Kafrelsheikh University   (Egypt)

^b GIFU UNIVERSITY   (Japan)

Author keywords

Argonaute proteins; Computational analysis; Gene silencing; Molecular docking; PAZ domain; RNA interference

Indexed keywords

FREE ENERGY; GENE EXPRESSION; GENETIC ENGINEERING; MOLECULAR MODELING; RNA;

ARGONAUTE PROTEINS; CELLULAR PATHWAY; COMPUTATIONAL ANALYSIS; DOUBLE-STRANDED RNA; DROSOPHILLA; GENE SILENCING; IN-SILICO; MOLECULAR DOCKING; PAZ DOMAIN; RNA INTERFERENCE;

BINDING ENERGY;

ARGONAUTE 2 PROTEIN; NUCLEOTIDE; PROTEIN PAZ; UNCLASSIFIED DRUG; ARGONAUTE PROTEIN; SMALL INTERFERING RNA;

ARTICLE; BINDING SITE; BIOENERGY; COMPUTER MODEL; DATA ANALYSIS; DROSOPHILA; GENE SILENCING; MATHEMATICAL MODEL; MOLECULAR DOCKING; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN RNA BINDING; PROTEIN STRUCTURE; RNA INTERFERENCE; CHEMISTRY; COMPUTER SIMULATION; HUMAN; METABOLISM; PROTEIN TERTIARY STRUCTURE;

ARGONAUTE PROTEINS; BINDING SITES; COMPUTER SIMULATION; GENE SILENCING; HUMANS; MOLECULAR DOCKING SIMULATION; PROTEIN CONFORMATION; PROTEIN STRUCTURE, TERTIARY; RNA, SMALL INTERFERING;

EID: 84882259509     PISSN: 0920654X     EISSN: 15734951     Source Type: Journal    
DOI: 10.1007/s10822-013-9665-3     Document Type: Article

References (43)

1. Tian Y, Simanshu DK, Ma JB, Patel DJ (2011) Structural basis for piRNA 2′-O-methylated 3′-end recognition by Piwi PAZ (Piwi/Argonaute/ Zwille) domains. Proc Natl Acad Sci USA 108(3):903-910. doi: 10.1073/pnas.1017762108
2. Kim VN, Han J, Siomi MC (2009) Biogenesis of small RNAs in animals. Nat Rev Mol Cell Biol 10(2):126-139. doi: 10.1038/nrm2632
3. Frank F, Sonenberg N, Nagar B (2010) Structural basis for 5′-nucleotide base-specific recognition of guide RNA by human AGO2. Nature 465(7299):818-822. doi: 10.1038/nature09039
4. Yan KS, Yan S, Farooq A, Han A, Zeng L, Zhou MM (2003) Structure and conserved RNA binding of the PAZ domain. Nature 426(6965):468-474. doi: 10.1038/nature02129
5. Lingel A, Simon B, Izaurralde E, Sattler M (2004) Nucleic acid 3′-end recognition by the Argonaute2 PAZ domain. Nat Struct Mol Biol 11(6):576-577. doi: 10.1038/nsmb777
6. Crunkhorn S (2013) Trial watch: pioneering RNAi therapy shows antitumour activity in humans. Nat Rev Drug Discov 12(3):178. doi: 10.1038/nrd3962
7. Rao DD, Wang Z, Senzer N, Nemunaitis J (2013) RNA interference and personalized cancer therapy. Discov Med 15(81):101-110
8. Singhania R, Khairuddin N, Clarke D, McMillan NA (2012) RNA interference for the treatment of papillomavirus disease. Open Virol J 6:204-215. doi: 10.2174/1874357901206010204
9. Wang W, Liu C, Wang Y, Cao L (2013) Effects of the downregulation of SnoN expression on HepG2 cell proliferation and apoptosis. Mol Med Rep 7(4):1324-1328. doi: 10.3892/mmr.2013.1340
10. Wooddell CI, Rozema DB, Hossbach M, John M, Hamilton HL, Chu Q, Hegge JO, Klein JJ, Wakefield DH, Oropeza CE, Deckert J, Roehl I, Jahn-Hofmann K, Hadwiger P, Vornlocher HP, McLachlan A, Lewis DL (2013) Hepatocyte-targeted RNAi therapeutics for the treatment of chronic hepatitis B virus infection. Mol Ther. doi: 10.1038/mt.2013.31
11. Li H, Zhou S, Li T, Liu Z, Wu J, Zeng G, Liu C, Gong J (2012) Suppression of BCRP expression and restoration of sensitivity to chemotherapy in multidrug-resistant HCC Cell Line HEPG2/ADM by RNA interference. Hepatogastroenterology 59(119):2238-2242. doi: 10.5754/hge11781
12. Huang HY, Chiang BL (2009) siRNA as a therapy for asthma. Curr Opin Mol Ther 11(6):652-663
13. Seguin RM, Ferrari N (2009) Emerging oligonucleotide therapies for asthma and chronic obstructive pulmonary disease. Expert Opin Investig Drugs 18(10):1505-1517. doi: 10.1517/13543780903179294
14. Presumey J, Duroux-Richard I, Courties G, Apparailly F (2010) Cationic liposome formulations for RNAi-based validation of therapeutic targets in rheumatoid arthritis. Curr Opin Mol Ther 12(3):325-330
15. Courties G, Presumey J, Duroux-Richard I, Jorgensen C, Apparailly F (2009) RNA interference-based gene therapy for successful treatment of rheumatoid arthritis. Expert Opin Biol Ther 9(5):535-538. doi: 10.1517/14712590902926089
16. Li F, Mahato RI (2011) RNA interference for improving the outcome of islet transplantation. Adv Drug Deliv Rev 63(1-2):47-68. doi: 10.1016/j.addr.2010.11.003
17. Kubowicz P, Zelaszczyk D, Pekala E (2013) RNAi in Clinical Studies. Curr Med Chem 20(14):1801-1816. doi: 10.2174/09298673113209990118
18. Shi L, Cui S, Engel JD, Tanabe O (2013) Lysine-specific demethylase 1 is a therapeutic target for fetal hemoglobin induction. Nat Med. doi: 10.1038/nm.3101
19. Kandeel M, Kitade Y (2013) Computational analysis of siRNA recognition by the Ago2 PAZ domain and identification of the determinants of RNA-induced gene silencing. PLoS ONE 8(2):e57140. doi: 10.1371/journal.pone.0057140
20. Wang Y, Juranek S, Li H, Sheng G, Wardle GS, Tuschl T, Patel DJ (2009) Nucleation, propagation and cleavage of target RNAs in Ago silencing complexes. Nature 461(7265):754-761. doi: 10.1038/nature08434
21. Gu S, Jin L, Huang Y, Zhang F, Kay MA (2012) Slicing-independent RISC activation requires the argonaute PAZ domain. Curr Biol 22(16):1536-1542. doi: 10.1016/j.cub.2012.06.040
22. Somoza A, Terrazas M, Eritja R (2010) Modified siRNAs for the study of the PAZ domain. Chem Commun (Camb) 46(24):4270-4272. doi: 10.1039/c003221b
23. Yoshikawa K, Ogata A, Matsuda C, Kohara M, Iba H, Kitade Y, Ueno Y (2011) Incorporation of biaryl units into the 5′ and 3′ ends of sense and antisense strands of siRNA duplexes improves strand selectivity and nuclease resistance. Bioconjug Chem 22(1):42-49. doi: 10.1021/bc100301w
24. Gong W, Desaulniers JP (2012) Gene-silencing properties of siRNAs that contain internal amide-bond linkages. Bioorg Med Chem Lett 22(22):6934-6937. doi: 10.1016/j.bmcl.2012.09.009
25. Avino A, Ocampo SM, Perales JC, Eritja R (2012) Synthesis and in vitro inhibition properties of siRNA conjugates carrying acridine and quindoline moieties. Chem Biodivers 9(3):557-566. doi: 10.1002/cbdv.201100321
26. Zeng L, Zhang Q, Yan K, Zhou MM (2011) Structural insights into piRNA recognition by the human PIWI-like 1 PAZ domain. Proteins 79(6):2004-2009. doi: 10.1002/prot.23003
27. Elkayam E, Kuhn CD, Tocilj A, Haase AD, Greene EM, Hannon GJ, Joshua-Tor L (2012) The structure of human argonaute-2 in complex with miR-20a. Cell 150(1):100-110. doi: 10.1016/j.cell.2012.05.017
28. Schirle NT, MacRae IJ (2012) The crystal structure of human Argonaute2. Science 336(6084):1037-1040. doi: 10.1126/science.1221551
29. Taniho K, Nakashima R, Kandeel M, Kitamura Y, Kitade Y (2012) Synthesis and biological properties of chemically modified siRNAs bearing 1-deoxy-D-ribofuranose in their 3′-overhang region. Bioorg Med Chem Lett 22(7):2518-2521. doi: 10.1016/j.bmcl.2012.01.132
30. Kuboe S, Yoda M, Ogata A, Kitade Y, Tomari Y, Ueno Y (2010) Diazirine-containing RNA photocrosslinking probes for the study of siRNA-protein interactions. Chem Commun (Camb) 46(39):7367-7369. doi: 10.1039/c0cc02450c
31. Ueno Y, Komatsuzaki S, Takasu K, Kitamura Y, Kitade Y (2009) Synthesis and properties of oligodeoxynucleotides containing biaryl units. Nucleic Acids Symp Ser (Oxf) 53:27-28. doi: 10.1093/nass/nrp014
32. Ueno Y, Watanabe Y, Shibata A, Yoshikawa K, Takano T, Kohara M, Kitade Y (2009) Synthesis of nuclease-resistant siRNAs possessing universal overhangs. Bioorg Med Chem 17(5):1974-1981. doi: 10.1016/j.bmc.2009.01.033
33. Ueno Y, Inoue T, Yoshida M, Yoshikawa K, Shibata A, Kitamura Y, Kitade Y (2008) Synthesis of nuclease-resistant siRNAs possessing benzene-phosphate backbones in their 3′-overhang regions. Bioorg Med Chem Lett 18(19):5194-5196. doi: 10.1016/j.bmcl.2008.08.086
34. Ueno Y, Kawada K, Shibata A, Yoshikawa K, Wataya Y, Kitade Y (2008) Synthesis and silencing properties of siRNAs possessing lipophilic groups at their 3′-termini. Nucleic Acids Symp Ser (Oxf) 52:503-504. doi: 10.1093/nass/nrn255
35. Ueno Y, Kato T, Sato K, Ito Y, Yoshida M, Inoue T, Shibata A, Ebihara M, Kitade Y (2005) Synthesis and properties of nucleic acid analogues consisting of a benzene-phosphate backbone. J Org Chem 70(20):7925-7935. doi: 10.1021/jo050635m
36. Hsu KC, Chen YF, Lin SR, Yang JM (2011) iGEMDOCK: a graphical environment of enhancing GEMDOCK using pharmacological interactions and post-screening analysis. BMC Bioinformatics 12(Suppl 1):S33. doi: 10.1186/1471210512S1S33
37. Li Y, Frenz CM, Li Z, Chen M, Wang Y, Li F, Luo C, Sun J, Bohlin L, Yang H, Wang C (2011) Virtual and in vitro bioassay screening of phytochemical inhibitors from flavonoids and isoflavones against xanthine oxidase and cyclooxygenase-2 for gout treatment. Chem Biol Drug Des. doi: 10.1111/j.17470285.2011.01248.x
38. Bikadi Z, Hazai E (2009) Application of the PM6 semi-empirical method to modeling proteins enhances docking accuracy of AutoDock. J Cheminform 1:15. doi: 10.1186/17582946115
39. Morris GM, Goodsell DS, Halliday RS, Huey R, Hart WE, Belew RK, Olson AJ (1998) Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J Comput Chem 19(14):1639-1662. doi: 10.1002/(sici)1096987x(19981115)19:14<1639:aidjcc10>3.0.co;2b
40. Song JJ, Liu J, Tolia NH, Schneiderman J, Smith SK, Martienssen RA, Hannon GJ, Joshua-Tor L (2003) The crystal structure of the Argonaute2 PAZ domain reveals an RNA binding motif in RNAi effector complexes. Nat Struct Biol 10(12):1026-1032. doi: 10.1038/nsb1016
41. Lingel A, Simon B, Izaurralde E, Sattler M (2003) Structure and nucleic-acid binding of the Drosophila Argonaute 2 PAZ domain. Nature 426(6965):465-469. doi: 10.1038/nature02123
42. Tomari Y, Zamore PD (2005) Perspective: machines for RNAi. Genes Dev 19(5):517-529. doi: 10.1101/gad.1284105
43. Lee-Fowler TM, Guntur V, Dodam J, Cohn LA, DeClue AE, Reinero CR (2012) The tyrosine kinase inhibitor masitinib blunts airway inflammation and improves associated lung mechanics in a feline model of chronic allergic asthma. Int Arch Allergy Immunol 158(4):369-374. doi: 10.1159/000335122